Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Alberti

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Nutrition & Metabolism|February 25, 2010
Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP)Silvia Mirandola, David Bowman, Mahmood M Hussain, et al.
Annals of Internal Medicine|December 18, 2002
Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infectionAlfredo Alberti, Franco Noventa, Luisa Benvegnù, et al.
World Journal of Gastroenterology|October 7, 2008
Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulinValter Donadon, Massimiliano Balbi, Pietro Casarin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 24, 2016
Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in ItalyUmberto Restelli, Alfredo Alberti, Adriano Lazzarin, et al.
Journal of Medical Virology|May 13, 2016
Literature review of the distribution of hepatitis C virus genotypes across EuropeAlfredo Alberti, Laure Lacoin, Edith Morais, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Reciprocal interference between insulin and interferon-alpha signaling in hepatic cells: a vicious circle of clinical significance?Lisa Franceschini, Stefano Realdon, Moira Marcolongo, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 26, 2016
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasmaGiulio Nannetti, Silvana Pagni, Saverio G Parisi, et al.
Journal of Hepatology|December 17, 2009
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis CLaurent Castéra, Giada Sebastiani, Brigitte Le Bail, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 4, 2011
Comparable performance of TMA and Real-Time PCR in detecting minimal residual hepatitis C viraemia at the end of antiviral therapyGladis Bortoletto, Davide Campagnolo, Silvia Mirandola, et al.
Antiviral Therapy|November 13, 2004
PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis CMartina Gerotto, Francesca Dal Pero, Gladis Bortoletto, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Nutrition & Metabolism|February 25, 2010
Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP)Silvia Mirandola, David Bowman, Mahmood M Hussain, et al.
Annals of Internal Medicine|December 18, 2002
Prevalence of liver disease in a population of asymptomatic persons with hepatitis C virus infectionAlfredo Alberti, Franco Noventa, Luisa Benvegnù, et al.
World Journal of Gastroenterology|October 7, 2008
Association between hepatocellular carcinoma and type 2 diabetes mellitus in Italy: potential role of insulinValter Donadon, Massimiliano Balbi, Pietro Casarin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 24, 2016
Cost-effectiveness analysis of the use of daclatasvir + sofosbuvir + ribavirin (16 weeks and 12 weeks) vs sofosbuvir + ribavirin (16 weeks and 24 weeks) for the treatment of cirrhotic patients affected with hepatitis C virus genotype 3 in ItalyUmberto Restelli, Alfredo Alberti, Adriano Lazzarin, et al.
Journal of Medical Virology|May 13, 2016
Literature review of the distribution of hepatitis C virus genotypes across EuropeAlfredo Alberti, Laure Lacoin, Edith Morais, et al.
Hepatology (Baltimore, Md.)|May 4, 2011
Reciprocal interference between insulin and interferon-alpha signaling in hepatic cells: a vicious circle of clinical significance?Lisa Franceschini, Stefano Realdon, Moira Marcolongo, et al.
Journal of Pharmaceutical and Biomedical Analysis|January 26, 2016
Development of a simple HPLC-UV method for the determination of the hepatitis C virus inhibitor simeprevir in human plasmaGiulio Nannetti, Silvana Pagni, Saverio G Parisi, et al.
Journal of Hepatology|December 17, 2009
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis CLaurent Castéra, Giada Sebastiani, Brigitte Le Bail, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 4, 2011
Comparable performance of TMA and Real-Time PCR in detecting minimal residual hepatitis C viraemia at the end of antiviral therapyGladis Bortoletto, Davide Campagnolo, Silvia Mirandola, et al.
Antiviral Therapy|November 13, 2004
PKR gene expression and response to pegylated interferon plus ribavirin therapy in chronic hepatitis CMartina Gerotto, Francesca Dal Pero, Gladis Bortoletto, et al.
Pageof 6